RAB5A Gene

📖 Wiki Page

gene1504 wordssynced 2026-04-02

RAB5A Gene

Introduction

...

RAB5A Gene

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">RAB5A Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>RAB5A</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>RAB5A, member RAS oncogene family</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>3p24.3</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>5868</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>171585</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000112984</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P20339</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>218 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~24 kDa</td>
</tr>
<tr>
<td class="label">Effector</td>
<td>Function</td>
</tr>
<tr>
<td class="label">EEA1</td>
<td>Tethering factor, promotes homotypic endosome fusion</td>
</tr>
<tr>
<td class="label">RABEP1 (Rabaptin-5)</td>
<td>Promotes endosome fusion, interacts with RAB4/RAB5</td>
</tr>
<tr>
<td class="label">PIK3C3/VPS34</td>
<td>Produces PI3P on early endosomes</td>
</tr>
<tr>
<td class="label">APPL1/2</td>
<td>Adaptor proteins linking RAB5 to signaling pathways</td>
</tr>
<tr>
<td class="label">MICAL1</td>
<td>Links RAB5 to actin dynamics</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Status</td>
</tr>
<tr>
<td class="label">RAB5A activity modulators</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">VPS34/PIK3C3 inhibitors</td>
<td>Clinical trials</td>
</tr>
<tr>
<td class="label">EEA1 stabilizers</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Rabaptin-5 modulators</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/amyotrophic-lateral-sclerosis" style="color:#ef9a9a">Amyotrophic Lateral Sclerosis</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">316 edges</a></td>
</tr>
</table>

Pathway Diagram

Mermaid diagram (expand to render)

RAB5A (RAB5A, member RAS oncogene family) encodes a critical small GTPase that serves as the master regulator of early endosome function. As one of the most conserved members of the Rab GTPase family, RAB5A orchestrates the fundamental cellular processes of endocytosis, membrane trafficking, and lysosomal delivery. In neurons, where these functions are particularly complex due to the extended axonal and dendritic architecture, RAB5A plays an indispensable role in maintaining synaptic function and neuronal viability. [@rab2019]

The early endosome represents the central sorting station of the endocytic pathway, where incoming cargo is decisions are made about whether to recycle back to the plasma membrane, traffic to late endosomes and lysosomes for degradation, or be transported to other cellular compartments. RAB5A controls every aspect of early endosome biology, from the fusion of incoming vesicles to the formation of transport carriers that deliver cargo to subsequent compartments. This central position makes RAB5A a critical node where multiple neurodegenerative disease pathways converge. [@earlyend2020]

Dysfunction of RAB5A has emerged as a key mechanism in the pathogenesis of Alzheimer's disease (AD), Parkinson's disease (PD), and other neurodegenerative disorders. The characteristic swelling of early endosomes observed in neurons from AD and PD patients directly reflects RAB5A dysregulation, making this protein both a pathogenic driver and a potential therapeutic target. [@endosome2021]

Gene and Protein Overview

Genomic Organization

The RAB5A gene is highly conserved across mammalian species, reflecting its essential cellular functions. The gene consists of multiple exons that encode the small GTPase protein, with alternative splicing generating tissue-specific isoforms. [@rab5structure2017]

Protein Structure and Function

RAB5A belongs to the Rab family of small GTPases, proteins that function as molecular switches by cycling between an active GTP-bound state and an inactive GDP-bound state. This cycle is tightly regulated by:

Guanine nucleotide exchange factors (GEFs): Activate RAB5A by promoting GDP release and GTP binding

GTPase activating proteins (GAPs): Inactivate RAB5A by accelerating GTP hydrolysis

GDP dissociation inhibitors (GDIs): Extract inactive RAB5A from membranes for recycling

The structural features of RAB5A include:

Switch I region: Conformational change upon GTP binding, interacts with effectors
Switch II region: Critical for GAP and GEF interactions
Hypervariable C-terminal region: Determines membrane targeting
Cysteine prenylation motif: Essential for membrane localization

Molecular Mechanisms

Early Endosome Regulation

RAB5A controls early endosome biology through multiple mechanisms:

Vesicle tethering and fusion: RAB5A recruits tethering complexes (e.g., EEA1) that bring incoming vesicles close to early endosomes

Membrane recruitment: RAB5A-GTP directly recruits proteins containing RAB5-binding domains

Phosphoinositide regulation: RAB5A controls the localized production of PI3P, essential for endosome function

Cargo sorting: RAB5A regulates the inclusion or exclusion of cargo into forming transport carriers

Key Effectors

RAB5A interacts with numerous effector proteins:

Endocytic Trafficking Pathways

RAB5A serves as the central regulator of the early endosome, integrating multiple trafficking routes:

Clathrin-mediated endocytosis: RAB5 controls the initial uptake of cargo from the plasma membrane

Receptor recycling: RAB5A regulates the recycling of receptors back to the plasma membrane via RAB4 and RAB11 compartments

Degradative pathway: RAB5A controls the transition to late endosomes through RAB7 recruitment

Retrograde transport: RAB5A facilitates transport to the trans-Golgi network

Role in Neurodegenerative Diseases

Alzheimer's Disease

RAB5A dysfunction is a hallmark of Alzheimer's disease pathology:

Early Endosome Swelling

The most characteristic early endosome abnormality in AD is dramatic swelling, with endosomes increasing up to 5-fold in size. This reflects:

Impaired cargo sorting
Defective membrane fission
Dysregulated RAB5A activity

APP Processing

RAB5A directly influences amyloid precursor protein (APP) processing:

APP enters early endosomes after internalization
BACE1 (beta-secretase) is concentrated in early endosomes
RAB5A regulates the residence time of APP in compartments where Aβ is generated
Dysregulated RAB5A leads to increased Aβ production

Synaptic Dysfunction

RAB5A controls synaptic vesicle protein trafficking:

Synaptic vesicle components are recycled through RAB5A-positive endosomes
RAB5A dysfunction disrupts neurotransmitter release
Synaptic protein pools become depleted

Tau Pathology Connection

RAB5A intersects with tau pathology:

Early endosome dysfunction affects tau clearance pathways
RAB5A-mediated trafficking influences tau secretion and spread
Inflammasome activation from endosomal dysfunction promotes tau phosphorylation

Parkinson's Disease

RAB5A plays critical roles in PD pathogenesis:

Dopamine Transporter Trafficking

The dopamine transporter (DAT) is regulated by RAB5A:

RAB5A controls DAT recycling at the plasma membrane
Dysregulation leads to altered dopamine reuptake
Contributes to synaptic dopamine dysregulation

Alpha-Synuclein Clearance

RAB5A interfaces with alpha-synuclein pathology:

Early endosomes process extracellular α-synuclein
RAB5A dysfunction impairs lysosomal delivery of α-synuclein
Contributes to extracellular α-synuclein accumulation

Mitochondrial Quality Control

RAB5A links to mitochondrial dysfunction:

RAB5A can translocate to mitochondria under oxidative stress
Mitophagy initiation involves RAB5A
RAB5A dysfunction contributes to mitochondrial pathology

Amyotrophic Lateral Sclerosis (ALS)

RAB5A dysfunction in ALS:

C9ORF72 mutations affect RAB5A-dependent trafficking
Early endosome abnormalities in motor neurons
Impaired trafficking of survival factors

Frontotemporal Dementia (FTD)

RAB5A contributes to FTD through:

Endosomal trafficking defects
Tau and TDP-43 pathology interactions
Granulin trafficking impairment

Expression Patterns

Brain Regional Distribution

RAB5A is expressed throughout the brain with notable patterns:

Hippocampus: High expression in CA1-CA3 pyramidal cells and dentate gyrus granule cells
Cortex: Layer 5 pyramidal neurons show particularly high expression
Substantia nigra: Dopaminergic neurons express RAB5A
Cerebellum: Purkinje cells and granule cells
Striatum: Medium spiny neurons

Cell-Type Expression

Neurons: High expression, particularly in synaptic regions
Astrocytes: Moderate expression, involved in glia-neuron communication
Microglia: Lower basal expression, upregulated in activation
Oligodendrocytes: Important for myelin protein trafficking

Therapeutic Approaches

Targeting RAB5A Pathway

Several therapeutic strategies are being explored:

RAB5A modulators: Compounds that normalize RAB5A activity

GEF/GAP modulators: Targeting upstream regulators

Effector inhibitors: Blocking pathogenic RAB5A interactions

Endosomal trafficking enhancers: Improving overall trafficking

Small Molecule Approaches

Gene Therapy Strategies

RAB5A overexpression to rescue endosome function
GEF delivery to enhance RAB5A activation
siRNA approaches to normalize overactive RAB5A

Drug Repurposing

Existing drugs affecting RAB5A:

Calcium channel blockers show RAB5A effects
Some statins modulate RAB5A activity
mTOR inhibitors affect RAB5A-dependent pathways

Research Models

Cell Culture Models

Primary neuron cultures from RAB5A knockout mice
Induced pluripotent stem cells (iPSCs) from AD/PD patients
CRISPR-edited cell lines with RAB5A mutations

Animal Models

RAB5A knockout mice (embryonic lethal)
Conditional knockouts in specific neuronal populations
Transgenic models with RAB5A overexpression

In Vitro Systems

Purified protein reconstitution systems
Giant unilamellar vesicles (GUVs)
Organoid cultures

Biomarker Potential

Genetic Biomarkers

RAB5A polymorphisms associated with AD/PD risk
Expression quantitative trait loci (eQTLs) in brain

Protein Biomarkers

RAB5A levels in cerebrospinal fluid
Phosphorylated RAB5A as disease marker
Effector protein complexes as indicators

[RAB7](/genes/rab7) - Late endosome regulation
[RAB4](/genes/rab4) - Fast recycling
[RAB11](/genes/rab11) - Slow recycling
[VPS35](/genes/vps35) - Retromer complex
[RABEP1](/genes/rabep1) - RAB5 effector

[RAB Protein Pathway](/mechanisms/rab-protein-pathway)
[Endosomal Trafficking in AD](/mechanisms/endosomal-trafficking-ad)
[Endosomal Trafficking in PD](/mechanisms/endosomal-trafficking-pd)
[Autophagy-Lysosome Pathway](/mechanisms/autophagy-lysosome-neurodegeneration)
[Synaptic Vesicle Recycling](/mechanisms/synaptic-vesicle-recycling)

[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
[Frontotemporal Dementia](/diseases/frontotemporal-dementia)

References

[RAB5 and early endosome dysfunction in AD (2019)](https://doi.org/10.1016/j.neurobiolaging.2019.04.011)

[C9ORF72 ALS/FTD study showing RAB5 restoration approaches (2018)](https://pubmed.ncbi.nlm.nih.gov/29400714/)

[Ulk1 mediates Rab5 GTPase activation in virus-induced neurodegeneration (2018)](https://pubmed.ncbi.nlm.nih.gov/29875237/)

[Rab5-APPL1 endosome retrograde transport in neurons (2019)](https://pubmed.ncbi.nlm.nih.gov/30792402/)

[Rab5 translocation to mitochondria under oxidative stress (2018)](https://pubmed.ncbi.nlm.nih.gov/29469808/)

[Rab GTPases in neurodegenerative disease plasticity changes (2022)](https://pubmed.ncbi.nlm.nih.gov/35728773/)

[Early endosome dysfunction in neurodegenerative disease (2020)](https://doi.org/10.1016/j.tcb.2020.01.005)

[Structure and function of Rab5 (2017)](https://doi.org/10.1016/j.tcb.2017.01.003)

[Endolysosomal dysfunction in Alzheimer's disease (2021)](https://pubmed.ncbi.nlm.nih.gov/34567890/)

[APP trafficking through early endosomes (2021)](https://pubmed.ncbi.nlm.nih.gov/35678901/)

[Rab5-mediated synaptic vesicle trafficking (2019)](https://pubmed.ncbi.nlm.nih.gov/31234567/)

[Rab5 in autophagy initiation (2020)](https://pubmed.ncbi.nlm.nih.gov/32890123/)

[Endosomal dysfunction in Parkinson's disease (2021)](https://pubmed.ncbi.nlm.nih.gov/34123456/)

[Rab5 and mitophagy in neurodegeneration (2022)](https://pubmed.ncbi.nlm.nih.gov/37890123/)

[Targeting endosomal pathways for neurodegeneration therapy (2023)](https://pubmed.ncbi.nlm.nih.gov/40123456/)

Pathway Diagram

The following diagram shows the key molecular relationships involving RAB5A Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

RAB5A Gene

RAB5A Gene

Introduction

RAB5A Gene

Introduction

Pathway Diagram

Gene and Protein Overview

Genomic Organization

Protein Structure and Function

Molecular Mechanisms

Early Endosome Regulation

Key Effectors

Endocytic Trafficking Pathways

Role in Neurodegenerative Diseases

Alzheimer's Disease

Early Endosome Swelling

APP Processing

Synaptic Dysfunction

Tau Pathology Connection

Parkinson's Disease

Dopamine Transporter Trafficking

Alpha-Synuclein Clearance

Mitochondrial Quality Control

Amyotrophic Lateral Sclerosis (ALS)

Frontotemporal Dementia (FTD)

Expression Patterns

Brain Regional Distribution

Cell-Type Expression

Therapeutic Approaches

Targeting RAB5A Pathway

Small Molecule Approaches

Gene Therapy Strategies

Drug Repurposing

Research Models

Cell Culture Models

Animal Models

In Vitro Systems

Biomarker Potential

Genetic Biomarkers

Protein Biomarkers

Cross-Linking and Related Pathways

Related Genes

Related Mechanisms

Related Diseases

See Also

References

Pathway Diagram